1. Home
  2. KRRO vs WIW Comparison

KRRO vs WIW Comparison

Compare KRRO & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRRO
  • WIW
  • Stock Information
  • Founded
  • KRRO 2014
  • WIW 2004
  • Country
  • KRRO United States
  • WIW United States
  • Employees
  • KRRO N/A
  • WIW N/A
  • Industry
  • KRRO Biotechnology: Pharmaceutical Preparations
  • WIW Finance Companies
  • Sector
  • KRRO Health Care
  • WIW Finance
  • Exchange
  • KRRO Nasdaq
  • WIW Nasdaq
  • Market Cap
  • KRRO 490.1M
  • WIW 524.3M
  • IPO Year
  • KRRO 2019
  • WIW N/A
  • Fundamental
  • Price
  • KRRO $43.67
  • WIW $8.37
  • Analyst Decision
  • KRRO Strong Buy
  • WIW
  • Analyst Count
  • KRRO 7
  • WIW 0
  • Target Price
  • KRRO $133.83
  • WIW N/A
  • AVG Volume (30 Days)
  • KRRO 132.1K
  • WIW 229.9K
  • Earning Date
  • KRRO 11-12-2024
  • WIW 01-01-0001
  • Dividend Yield
  • KRRO N/A
  • WIW 11.14%
  • EPS Growth
  • KRRO N/A
  • WIW N/A
  • EPS
  • KRRO N/A
  • WIW N/A
  • Revenue
  • KRRO N/A
  • WIW N/A
  • Revenue This Year
  • KRRO N/A
  • WIW N/A
  • Revenue Next Year
  • KRRO N/A
  • WIW N/A
  • P/E Ratio
  • KRRO N/A
  • WIW N/A
  • Revenue Growth
  • KRRO N/A
  • WIW N/A
  • 52 Week Low
  • KRRO $30.01
  • WIW $8.01
  • 52 Week High
  • KRRO $98.00
  • WIW $9.37
  • Technical
  • Relative Strength Index (RSI)
  • KRRO 43.00
  • WIW 28.17
  • Support Level
  • KRRO $41.03
  • WIW $8.51
  • Resistance Level
  • KRRO $52.00
  • WIW $8.59
  • Average True Range (ATR)
  • KRRO 6.03
  • WIW 0.06
  • MACD
  • KRRO 0.03
  • WIW -0.03
  • Stochastic Oscillator
  • KRRO 42.36
  • WIW 11.25

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About WIW Western Asset Inflation-Linked Opportunities & Income Fund

Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.

Share on Social Networks: